Jan Joseph Melenhorst

28PUBLICATIONS
130CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Sensory processes, perception and performanceCritical approaches to crime
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 10, 2025
Fine tuning towards the next generation of engineered T cells.

Tham T Nguyen, Patrick Ho, Sarah Staudt

|Sep 05, 2025
MCL1 may not mediate chemoresistance.

Kylin A Emhoff, Kunho Chung, Dongmei Zhang

|May 19, 2025
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Mantle Cell Lymphoma.

Arun Kumar Arunachalam, Cassandra K Gilmour, Jan Joseph Melenhorst

|Feb 13, 2025
Leveraging Vector-Based Gene Disruptions to Enhance CAR T-Cell Effectiveness.

Beatriz C Oliveira, Saaurav Bari, J Joseph Melenhorst

|Jan 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.

Julie K Jadlowsky, Elizabeth O Hexner, Amy Marshall

|Dec 17, 2024
Navigating CAR-T cell therapy long-term complications.

Céline Grégoire, J Joseph Melenhorst

Pageof 5

Frequent Collaborators

9 joint publications

Carl H June

8 joint publications

Bruce L Levine

4 joint publications

Joseph A Fraietta

4 joint publications

Stephan A Grupp